267 related articles for article (PubMed ID: 19332244)
21. Surgical management of women with ovarian cancer.
Cooper A; DePriest P
Semin Oncol; 2007 Jun; 34(3):226-33. PubMed ID: 17560984
[TBL] [Abstract][Full Text] [Related]
22. Recent surgical management of ovarian cancer.
Khoury-Collado F; Chi DS
J Obstet Gynaecol Res; 2011 May; 37(5):379-82. PubMed ID: 21463433
[TBL] [Abstract][Full Text] [Related]
23. [Intraperitoneal chemotherapy for ovarian cancer].
Noma J; Yoshida N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
[TBL] [Abstract][Full Text] [Related]
24. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Carter J; Durfee J
Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798
[TBL] [Abstract][Full Text] [Related]
25. [New approaches to the treatment of advanced ovarian cancer].
Ivanov S
Akush Ginekol (Sofiia); 2006; 45(4):20-3. PubMed ID: 16889195
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer: an overview.
Roett MA; Evans P
Am Fam Physician; 2009 Sep; 80(6):609-16. PubMed ID: 19817326
[TBL] [Abstract][Full Text] [Related]
27. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
Anderson NJ; Hacker ED
Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
[TBL] [Abstract][Full Text] [Related]
28. [INTRAVENOUS CHEMOTHERAPY VERSUS INTRAPERITONEAL CHEMOTHERAPY IN ADVANCED OVARIAN CANCER: UPDATE ON THE SITUATION WORLDWIDE AND IN ISRAEL].
Binyamin S; Segev Y; Auslender R; Bitterman A; Lavie O
Harefuah; 2015 Sep; 154(9):594-8, 607, 606. PubMed ID: 26665753
[TBL] [Abstract][Full Text] [Related]
29. [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?].
Morice P; Leblanc E; Narducci F; Pomel C; Pautier P; Chevalier A; Lhommé C; Castaigne D
Gynecol Obstet Fertil; 2005; 33(1-2):55-63. PubMed ID: 15752668
[TBL] [Abstract][Full Text] [Related]
30. Management of early ovarian cancer.
Young RC; Pecorelli S
Semin Oncol; 1998 Jun; 25(3):335-9. PubMed ID: 9633845
[TBL] [Abstract][Full Text] [Related]
31. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
Zivanovic O; Braun M; Park TW; Kuhn W
Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
[TBL] [Abstract][Full Text] [Related]
32. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
34. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer.
Markman M
Semin Oncol; 2006 Dec; 33(6 Suppl 12):S3-7. PubMed ID: 17223444
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion.
Wallach RC
Oncology (Williston Park); 2008 Nov; 22(13):1456; author reply 1456-7. PubMed ID: 19133602
[No Abstract] [Full Text] [Related]
37. Unresolved issues in the chemotherapeutic management of gynecologic malignancies.
Markman M
Semin Oncol; 2006 Apr; 33(2 Suppl 6):S33-8. PubMed ID: 16716801
[TBL] [Abstract][Full Text] [Related]
38. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.
Kang S; Nam BH
Ann Surg Oncol; 2009 Aug; 16(8):2315-20. PubMed ID: 19517192
[TBL] [Abstract][Full Text] [Related]
39. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
40. [Is there a standard therapy in advanced ovarian carcinoma?].
Köchli OR
Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
